| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Pharmacogenetic screening for drug therapy: From single gene markers to decision making in the next generation sequencing era
|
Tzvetkov, Mladen
|
|
2012
|
44 |
2 |
p. 166-180
15 p.
|
article
|
| 2 |
Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis
|
Liao, Gary J.W.
|
|
2012
|
44 |
2 |
p. 69-72
4 p.
|
article
|
| 3 |
Prostate cancer screening
|
Sikaris, Ken
|
|
2012
|
44 |
2 |
p. 99-109
11 p.
|
article
|
| 4 |
Screening for diabetes
|
Backholer, K.
|
|
2012
|
44 |
2 |
p. 110-114
5 p.
|
article
|
| 5 |
Screening for disease
|
Hickman, Peter E.
|
|
2012
|
44 |
2 |
p. 61-62
2 p.
|
article
|
| 6 |
Screening for disease in the newborn: the evidence base for blood-spot screening
|
Bridget, Wilcken
|
|
2012
|
44 |
2 |
p. 73-79
7 p.
|
article
|
| 7 |
Screening for familial hypercholesterolaemia
|
Bender, Robert
|
|
2012
|
44 |
2 |
p. 122-128
7 p.
|
article
|
| 8 |
Screening for hereditary haemochromatosis
|
Nadakkavukaran, Itty M.
|
|
2012
|
44 |
2 |
p. 148-152
5 p.
|
article
|
| 9 |
Screening for lipid disorders
|
Bell, Damon A.
|
|
2012
|
44 |
2 |
p. 115-121
7 p.
|
article
|
| 10 |
Screening for thyroid disease and iodine deficiency
|
Eastman, Creswell J.
|
|
2012
|
44 |
2 |
p. 153-159
7 p.
|
article
|
| 11 |
Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment
|
Glendenning, Paul
|
|
2012
|
44 |
2 |
p. 160-165
6 p.
|
article
|
| 12 |
Should we screen for iron deficiency anaemia? A review of the evidence and recent recommendations
|
Pasricha, Sant-Rayn
|
|
2012
|
44 |
2 |
p. 139-147
9 p.
|
article
|
| 13 |
Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates
|
Berger, Barry M.
|
|
2012
|
44 |
2 |
p. 80-88
9 p.
|
article
|
| 14 |
The ethics of screening for disease
|
Delatycki, Martin B.
|
|
2012
|
44 |
2 |
p. 63-68
6 p.
|
article
|
| 15 |
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers
|
Hopper, J.L.
|
|
2012
|
44 |
2 |
p. 89-98
10 p.
|
article
|
| 16 |
Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities
|
Eggers, Kai M.
|
|
2012
|
44 |
2 |
p. 129-138
10 p.
|
article
|
Journal description